Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, discusses a study conducted with Takeda and the Harris Poll ...

Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...

Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

Ma-Yi Theater Company and The Public Theater are set to bring the intense world of sumo wrestling to the stage with the New ...

When medical interventions fail, melanocyte keratinocyte transplantation may be the most advanced procedural option for ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...

The second round of the Founders Cup 2025 was played on Friday, February 7 at the Bradenton Country Club in Florida. The cut line was set at even par after 36 holes and 66 players made it through.

Day One Bio aims to bring new cancer therapies to pediatric patients faster amid evolving financial incentives, such as the ...